Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

94 studies match

clinicaltrialsPublishedShowing 51–94 of 94 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04960709	Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin(VOLGA)	active not recruiting	Phase 3	712	AstraZenecaINDUSTRY	25	Jun 4, 2026	clinicaltrials
NCT02972840	A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL	active not recruiting	Phase 3	635	Acerta Pharma BVINDUSTRY	27